Australia's first medical cannabis clinical trials to start in Victoria

Children living in the state of Victoria will be the first Australians to trial a synthetic medical cannabis treatment for uncontrollable epilepsy, according to the Herald Sun.

The clinical trial will cost $150,000 and is the first of its kind in Australia, with other states to possibly announce similar initiatives in the near future. It is hoped that if the trial is successful, it could pave the way for medical cannabis to become widely used as part of treatments for a variety of ailments and illnesses, in addition to epilepsy.

Up to 60 children and young adults aged between 1-17 years old will be given access to synthetic medical cannabis as part of three international trials run by Austin Health, a major private healthcare provider in Australia.

The clinical trials operated by Austin Health will focus on the non-psychoactive cannabidiol (CBD) part of the cannabis plant which various studies suggest could...

Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.